Newsfile Corp
08 Oct 2026, 21:52 UTC · 55m ago
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Pacira BioSciences, Inc. (PCRX)
Impact · against what's priced in
The announcement of a legal investigation into Pacira BioSciences' sale to Viatris introduces a common but potentially disruptive headwind to the deal's closing timeline. While typical in M&A, the investigation into whether shareholders are receiving fair value creates a small amount of execution risk for PCRX.
- PCRX−0.20
No priced-in read yet





